{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,12,15]],"date-time":"2024-12-15T05:09:28Z","timestamp":1734239368243,"version":"3.30.2"},"reference-count":40,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,11,5]],"date-time":"2024-11-05T00:00:00Z","timestamp":1730764800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.es","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cl\u00ednica e Investigaci\u00f3n en Arteriosclerosis"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1016\/j.arteri.2024.11.001","type":"journal-article","created":{"date-parts":[[2024,12,11]],"date-time":"2024-12-11T13:57:08Z","timestamp":1733925428000},"page":"S3-S12","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"S2","title":["Bases gen\u00e9ticas de las hipertrigliceridemias"],"prefix":"10.1016","volume":"36","author":[{"given":"Mar\u00eda Jos\u00e9","family":"Ariza Corbo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ovidio","family":"Mu\u00f1iz-Grijalvo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Agust\u00edn","family":"Blanco Echevarr\u00eda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9194-495X","authenticated-orcid":false,"given":"J.L.","family":"D\u00edaz-D\u00edaz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.arteri.2024.11.001_bib0205","doi-asserted-by":"crossref","first-page":"4791","DOI":"10.1093\/eurheartj\/ehab551","article-title":"Triglyceride-rich lipoproteins and their remnants: Metabolic insights, role in atherosclerotic cardiovascular disease, and emerging therapeutic strategies\u2014a consensus statement from the European Atherosclerosis Society","volume":"42","author":"Ginsberg","year":"2021","journal-title":"Eur Heart J"},{"key":"10.1016\/j.arteri.2024.11.001_bib0210","first-page":"130","article-title":"SEA 2022 Standards for Global Control of Cardiovascular Risk","volume":"34","author":"Mostaza","year":"2022","journal-title":"Clin Investig Arterioscler"},{"key":"10.1016\/j.arteri.2024.11.001_bib0215","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1146\/annurev-nutr-062222-020716","article-title":"Biosynthesis and Metabolism of ApoB-Containing Lipoproteins","volume":"44","author":"Lipoproteins","year":"2024","journal-title":"Annu Rev Nutr"},{"key":"10.1016\/j.arteri.2024.11.001_bib0220","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/bs.acc.2019.12.005","article-title":"Genomics of hypertriglyceridemia","volume":"97","author":"Tada","year":"2020","journal-title":"Adv Clin Chem"},{"issue":"Suppl 2","key":"10.1016\/j.arteri.2024.11.001_bib0225","first-page":"14","article-title":"Genetic basis of hypertriglyceridemies","volume":"33","author":"Cand\u00e1s-Est\u00e9banez","year":"2021","journal-title":"Clin Investig Arterioscler"},{"key":"10.1016\/j.arteri.2024.11.001_bib0230","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1016\/j.jacl.2021.07.004","article-title":"Prevalence of severe hypertriglyceridemia and pancreatitis in familial partial lipodystrophy type 2","volume":"15","author":"Lazarte","year":"2021","journal-title":"J Clin Lipidol"},{"key":"10.1016\/j.arteri.2024.11.001_bib0235","doi-asserted-by":"crossref","first-page":"2531","DOI":"10.1161\/ATVBAHA.119.313401","article-title":"Spectrum of Mutations and Long-Term Clinical Outcomes in Genetic Chylomicronemia Syndromes","volume":"39","author":"D\u2019Erasmo","year":"2019","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.arteri.2024.11.001_bib0240","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/gim.2015.30","article-title":"Standards and Guidelines for the Interpretation of Sequence Variants (ACMG, 2015)","volume":"17","author":"Richards","year":"2015","journal-title":"Genet Med"},{"key":"10.1016\/j.arteri.2024.11.001_bib0245","doi-asserted-by":"crossref","first-page":"104312","DOI":"10.1016\/j.ejmg.2021.104312","article-title":"DNA variant classification\u2013reconsidering \u201callele rarity\u201d and \u201cphenotype\u201d criteria in ACMG\/AMP guidelines","volume":"64","author":"Davieson","year":"2021","journal-title":"Eur J Med Genet"},{"key":"10.1016\/j.arteri.2024.11.001_bib0250","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1016\/j.jacl.2018.07.013","article-title":"Molecular basis of the familial chylomicronemia syndrome in patients from the National Dyslipidemia Registry of the Spanish Atherosclerosis Society","volume":"12","author":"Ariza","year":"2018","journal-title":"J Clin Lipidol"},{"key":"10.1016\/j.arteri.2024.11.001_bib0255","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1038\/nrendo.2015.26","article-title":"Chylomicronaemia-current diagnosis and future therapies","volume":"11","author":"Brahm","year":"2015","journal-title":"Nat Rev Endocrinol"},{"key":"10.1016\/j.arteri.2024.11.001_bib0260","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1111\/j.1365-2796.2012.02516.x","article-title":"Mutations in LPL, APOC2, APOA5, GPIHBP1 and LMF1 in patients with severe hypertriglyceridaemia","volume":"272","author":"Surendran","year":"2012","journal-title":"J Intern Med"},{"key":"10.1016\/j.arteri.2024.11.001_bib0265","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1016\/j.jacl.2018.03.093","article-title":"Clinical and biochemical features of different molecular etiologies of familial chylomicronemia","volume":"12","author":"Hegele","year":"2018","journal-title":"J Clin Lipidol"},{"key":"10.1016\/j.arteri.2024.11.001_bib0270","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.atherosclerosis.2018.12.019","article-title":"Chylomicronemia: Differences between familial chylomicronemia syndrome and multifactorial chylomicronemia","volume":"283","author":"Paquette","year":"2019","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.arteri.2024.11.001_bib0275","doi-asserted-by":"crossref","first-page":"e13345","DOI":"10.1111\/eci.13345","article-title":"Evaluation of the chylomicron-TG to VLDL-TG ratio for type I hyperlipoproteinemia diagnostic","volume":"50","author":"Rioja","year":"2020","journal-title":"Eur J Clin Invest"},{"key":"10.1016\/j.arteri.2024.11.001_bib0280","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jacl.2023.01.005","article-title":"Role of lipoprotein lipase activity measurement in the diagnosis of familial chylomicronemia syndrome","volume":"17","author":"Rioja","year":"2023","journal-title":"J Clin Lipidol"},{"key":"10.1016\/j.arteri.2024.11.001_bib0285","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1097\/MOL.0000000000000297","article-title":"Role of lipoprotein lipase in lipid metabolism","volume":"27","author":"Olivecrona","year":"2016","journal-title":"Curr Opin Lipidol"},{"key":"10.1016\/j.arteri.2024.11.001_bib0290","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.cca.2019.10.011","article-title":"Genetic variants in the LPL and GPIHBP1 genes, in patients with severe hypertriglyceridaemia, detected with high resolution melting analysis","volume":"500","author":"Ariza","year":"2020","journal-title":"Clin Chim Acta"},{"key":"10.1016\/j.arteri.2024.11.001_bib0295","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1073\/pnas.1817984116","article-title":"Structure of the lipoprotein lipase\u2013GPIHBP1 complex that mediates plasma triglyceride hydrolysis","volume":"116","author":"Birrane","year":"2019","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.arteri.2024.11.001_bib0300","doi-asserted-by":"crossref","first-page":"1856","DOI":"10.1172\/JCI115507","article-title":"Heterogeneous mutations in the human lipoprotein lipase gene in patients with familial lipoprotein lipase deficiency","volume":"88","author":"Gotoda","year":"1991","journal-title":"J Clin Invest"},{"key":"10.1016\/j.arteri.2024.11.001_bib0305","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.jacl.2015.09.007","article-title":"Novel mutations in the GPIHBP1 gene identified in 2 patients with recurrent acute pancreatitis","volume":"10","author":"Ariza","year":"2016","journal-title":"J Clin Lipidol"},{"key":"10.1016\/j.arteri.2024.11.001_bib0310","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.atherosclerosis.2019.01.004","article-title":"Deciphering the role of V200A and N291S mutations leading to LPL deficiency","volume":"282","author":"Botta","year":"2019","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.arteri.2024.11.001_bib0315","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.atherosclerosis.2016.01.010","article-title":"Multiple microRNA regulation of lipoprotein lipase gene abolished by 3\u2019UTR polymorphisms in a triglyceride-lowering haplotype harboring p.Ser474Ter","volume":"246","author":"Caussy","year":"2016","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.arteri.2024.11.001_bib0320","doi-asserted-by":"crossref","first-page":"115874","DOI":"10.1016\/j.biopha.2023.115874","article-title":"The GPIHBP1-LPL complex and its role in plasma triglyceride metabolism: Insights into chylomicronemia","volume":"169","author":"Jiang","year":"2023","journal-title":"Biomed Pharmacother"},{"key":"10.1016\/j.arteri.2024.11.001_bib0325","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.atherosclerosis.2021.02.020","article-title":"A novel GPIHBP1 mutation related to familial chylomicronemia syndrome: A series of cases","volume":"322","author":"Lima","year":"2021","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.arteri.2024.11.001_bib0330","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1097\/MPG.0000000000000363","article-title":"Whole-exome sequencing reveals GPIHBP1 mutations in infantile colitis with severe hypertriglyceridemia","volume":"59","author":"Gonzaga-Jauregui","year":"2014","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"10.1016\/j.arteri.2024.11.001_bib0335","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1007\/s11883-017-0665-y","article-title":"Update on APOA5 Genetics: Toward a Better Understanding of Its Physiological Impact","volume":"19","author":"Guardiola","year":"2017","journal-title":"Curr Atheroscler Rep"},{"key":"10.1016\/j.arteri.2024.11.001_bib0340","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1136\/bmjopen-2017-020016","article-title":"Effects of polymorphisms in APOA5 on the plasma levels of triglycerides and risk of coronary heart disease in Jilin, northeast China: A case-control study","volume":"8","author":"You","year":"2018","journal-title":"BMJ Open"},{"key":"10.1016\/j.arteri.2024.11.001_bib0345","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1097\/MOL.0b013e32833854c0","article-title":"Lipase maturation factor 1: Structure and role in lipase folding and assembly","volume":"21","author":"Doolittle","year":"2010","journal-title":"Curr Opin Lipidol"},{"key":"10.1016\/j.arteri.2024.11.001_bib0350","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1038\/ng.2007.24","article-title":"Mutations in LMF1 cause combined lipase deficiency and severe hypertriglyceridemia","volume":"39","author":"P\u00e9terfy","year":"2007","journal-title":"Nat Genet"},{"key":"10.1016\/j.arteri.2024.11.001_bib0355","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.5551\/jat.64697","article-title":"Identification of a Compound Heterozygous LMF1 Variants in a Patient with Severe Hypertriglyceridemia - Case Report and Literature Review","volume":"31","author":"Cao","year":"2024","journal-title":"J Atheroscler Thromb."},{"key":"10.1016\/j.arteri.2024.11.001_bib0360","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1097\/MOL.0000000000000680","article-title":"Apolipoprotein C-II: The re-emergence of a forgotten factor","volume":"31","author":"Wolska","year":"2020","journal-title":"Curr Opin Lipidol"},{"key":"10.1016\/j.arteri.2024.11.001_bib0365","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1186\/s12944-021-01531-8","article-title":"APOC3 genetic variation, serum triglycerides, and risk of coronary artery disease in Asian Indians, Europeans, and other ethnic groups","volume":"20","author":"Goyal","year":"2021","journal-title":"Lipids Health Dis"},{"key":"10.1016\/j.arteri.2024.11.001_bib0370","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.atherosclerosis.2020.08.017","article-title":"Common APOC3 variants are associated with circulating ApoC-III and VLDL cholesterol but not with total apolipoprotein B and coronary artery disease","volume":"311","author":"Silbernagel","year":"2020","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.arteri.2024.11.001_bib0375","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1093\/clinchem\/hvac213","article-title":"Diagnosis of Familial Dysbetalipoproteinemia Based on the Lipid Abnormalities Driven by APOE2\/E2 Genotype","volume":"69","author":"Bea","year":"2023","journal-title":"Clin Chem."},{"key":"10.1016\/j.arteri.2024.11.001_bib0380","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1126\/science.1142358","article-title":"Analysis Identifies Loci for Type 2 Diabetes and Triglyceride Levels","volume":"316","year":"2007","journal-title":"Science."},{"key":"10.1016\/j.arteri.2024.11.001_bib0385","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.ajhg.2011.11.028","article-title":"Transient infantile hypertriglyceridemia, fatty liver, and hepatic fibrosis caused by mutated GPD1, encoding glycerol-3-phosphate dehydrogenase 1","volume":"90","author":"Basel-Vanagaite","year":"2012","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.arteri.2024.11.001_bib0390","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1042\/BSR20140115","article-title":"Silencing of ANGPTL 3 (angiopoietin-like protein 3) in human hepatocytes results in decreased expression of gluconeogenic genes and reduced triacylglycerol-rich VLDL secretion upon insulin stimulation","volume":"34","author":"Tikka","year":"2014","journal-title":"Biosci Rep."},{"key":"10.1016\/j.arteri.2024.11.001_bib0395","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1097\/MOL.0b013e3283508fed","article-title":"The role of CREB-H transcription factor in triglyceride metabolism","volume":"23","author":"Lee","year":"2012","journal-title":"Curr Opin Lipidol"},{"key":"10.1016\/j.arteri.2024.11.001_bib0400","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1093\/brain\/awaa063","article-title":"Novel congenital disorder of O-linked glycosylation caused by GALNT2 loss of function","volume":"143","author":"Zilmer","year":"2020","journal-title":"Brain"}],"container-title":["Cl\u00ednica e Investigaci\u00f3n en Arteriosclerosis"],"original-title":[],"language":"es","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0214916824001086?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0214916824001086?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,12,14]],"date-time":"2024-12-14T09:59:15Z","timestamp":1734170355000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0214916824001086"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":40,"alternative-id":["S0214916824001086"],"URL":"https:\/\/doi.org\/10.1016\/j.arteri.2024.11.001","relation":{},"ISSN":["0214-9168"],"issn-type":[{"type":"print","value":"0214-9168"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Bases gen\u00e9ticas de las hipertrigliceridemias","name":"articletitle","label":"Article Title"},{"value":"Cl\u00ednica e Investigaci\u00f3n en Arteriosclerosis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.arteri.2024.11.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Espa\u00f1a, S.L.U. on behalf of Sociedad Espa\u00f1ola de Arteriosclerosis.","name":"copyright","label":"Copyright"}]}}